399 related articles for article (PubMed ID: 32279581)
1. VSMC-Specific Deletion of FAM3A Attenuated Ang II-Promoted Hypertension and Cardiovascular Hypertrophy.
Xiang R; Chen J; Li S; Yan H; Meng Y; Cai J; Cui Q; Yang Y; Xu M; Geng B; Yang J
Circ Res; 2020 Jun; 126(12):1746-1759. PubMed ID: 32279581
[TBL] [Abstract][Full Text] [Related]
2. Consequences of postnatal vascular smooth muscle EGFR deletion on acute angiotensin II action.
Schreier B; Hünerberg M; Rabe S; Mildenberger S; Bethmann D; Heise C; Sibilia M; Offermanns S; Gekle M
Clin Sci (Lond); 2016 Jan; 130(1):19-33. PubMed ID: 26438881
[TBL] [Abstract][Full Text] [Related]
3. Vascular smooth muscle cell-specific miRNA-214 knockout inhibits angiotensin II-induced hypertension through upregulation of Smad7.
Li Y; Li H; Xing W; Li J; Du R; Cao D; Wang Y; Yang X; Zhong G; Zhao Y; Sun W; Liu C; Gao X; Li Y; Liu Z; Jin X; Zhao D; Tan Y; Wang Y; Liu S; Yuan M; Song J; Chang YZ; Gao F; Ling S; Li Y
FASEB J; 2021 Nov; 35(11):e21947. PubMed ID: 34637552
[TBL] [Abstract][Full Text] [Related]
4. FAM3A promotes vascular smooth muscle cell proliferation and migration and exacerbates neointima formation in rat artery after balloon injury.
Jia S; Chen Z; Li J; Chi Y; Wang J; Li S; Luo Y; Geng B; Wang C; Cui Q; Guan Y; Yang J
J Mol Cell Cardiol; 2014 Sep; 74():173-82. PubMed ID: 24857820
[TBL] [Abstract][Full Text] [Related]
5. NLRP3 Gene Deletion Attenuates Angiotensin II-Induced Phenotypic Transformation of Vascular Smooth Muscle Cells and Vascular Remodeling.
Ren XS; Tong Y; Ling L; Chen D; Sun HJ; Zhou H; Qi XH; Chen Q; Li YH; Kang YM; Zhu GQ
Cell Physiol Biochem; 2017; 44(6):2269-2280. PubMed ID: 29262411
[TBL] [Abstract][Full Text] [Related]
6. The effects of angiotensin II, endothelin-1, and protein kinase C inhibitor on DNA synthesis and intracellular calcium mobilization in vascular smooth muscle cells from young normotensive and spontaneously hypertensive rats.
Rosen B; Barg J; Zimlichman R
Am J Hypertens; 1999 Dec; 12(12 Pt 1-2):1243-51. PubMed ID: 10619588
[TBL] [Abstract][Full Text] [Related]
7. Impaired Ca2+ signaling attenuates P2X receptor-mediated vasoconstriction of afferent arterioles in angiotensin II hypertension.
Zhao X; Cook AK; Field M; Edwards B; Zhang S; Zhang Z; Pollock JS; Imig JD; Inscho EW
Hypertension; 2005 Sep; 46(3):562-8. PubMed ID: 16116048
[TBL] [Abstract][Full Text] [Related]
8. Diallyl Trisulfide Suppresses Angiotensin II-Induced Vascular Remodeling Via Inhibition of Mitochondrial Fission.
Lu ZY; Qi J; Yang B; Cao HL; Wang RY; Wang X; Chi RF; Guo CL; Yang ZM; Liu HM; Li B
Cardiovasc Drugs Ther; 2020 Oct; 34(5):605-618. PubMed ID: 32564303
[TBL] [Abstract][Full Text] [Related]
9. Dimethylarginine dimethylaminohydrolase-1 mediates inhibitory effect of interleukin-10 on angiotensin II-induced hypertensive effects in vascular smooth muscle cells of spontaneously hypertensive rats.
Kim HY; Kim HS
Cytokine; 2016 Jan; 77():203-10. PubMed ID: 26375520
[TBL] [Abstract][Full Text] [Related]
10. Upregulation of interleukin-8/CXCL8 in vascular smooth muscle cells from spontaneously hypertensive rats.
Kim HY; Kang YJ; Song IH; Choi HC; Kim HS
Hypertens Res; 2008 Mar; 31(3):515-23. PubMed ID: 18497472
[TBL] [Abstract][Full Text] [Related]
11. Group VIA phospholipase A2 (iPLA2beta) participates in angiotensin II-induced transcriptional up-regulation of regulator of g-protein signaling-2 in vascular smooth muscle cells.
Xie Z; Gong MC; Su W; Turk J; Guo Z
J Biol Chem; 2007 Aug; 282(35):25278-89. PubMed ID: 17613534
[TBL] [Abstract][Full Text] [Related]
12. Involvement of profilin-1 in angiotensin II-induced vascular smooth muscle cell proliferation.
Cheng JF; Ni GH; Chen MF; Li YJ; Wang YJ; Wang CL; Yuan Q; Shi RZ; Hu CP; Yang TL
Vascul Pharmacol; 2011; 55(1-3):34-41. PubMed ID: 21586339
[TBL] [Abstract][Full Text] [Related]
13. Sulfatase 1 mediates the attenuation of Ang II-induced hypertensive effects by CCL5 in vascular smooth muscle cells from spontaneously hypertensive rats.
Cha HJ; Kim HY; Kim HS
Cytokine; 2018 Oct; 110():1-8. PubMed ID: 29684635
[TBL] [Abstract][Full Text] [Related]
14. Mitogen-activated protein/extracellular signal-regulated kinase inhibition attenuates angiotensin II-mediated signaling and contraction in spontaneously hypertensive rat vascular smooth muscle cells.
Touyz RM; El Mabrouk M; He G; Wu XH; Schiffrin EL
Circ Res; 1999 Mar; 84(5):505-15. PubMed ID: 10082472
[TBL] [Abstract][Full Text] [Related]
15. DP1 (Prostaglandin D
Zou F; Li Y; Zhang S; Zhang J
Hypertension; 2022 Jun; 79(6):1203-1215. PubMed ID: 35354317
[TBL] [Abstract][Full Text] [Related]
16. Caveolin-1 prevents sustained angiotensin II-induced resistance artery constriction and obesity-induced high blood pressure.
Czikora I; Feher A; Lucas R; Fulton DJ; Bagi Z
Am J Physiol Heart Circ Physiol; 2015 Mar; 308(5):H376-85. PubMed ID: 25527780
[TBL] [Abstract][Full Text] [Related]
17. Calcium/calmodulin-dependent kinase II inhibition in smooth muscle reduces angiotensin II-induced hypertension by controlling aortic remodeling and baroreceptor function.
Prasad AM; Morgan DA; Nuno DW; Ketsawatsomkron P; Bair TB; Venema AN; Dibbern ME; Kutschke WJ; Weiss RM; Lamping KG; Chapleau MW; Sigmund CD; Rahmouni K; Grumbach IM
J Am Heart Assoc; 2015 Jun; 4(6):e001949. PubMed ID: 26077587
[TBL] [Abstract][Full Text] [Related]
18. HDAC5 inhibition reduces angiotensin II-induced vascular contraction, hypertrophy, and oxidative stress in a mouse model.
Bai L; Kee HJ; Choi SY; Seok YM; Kim GR; Kee SJ; Kook H; Jeong MH
Biomed Pharmacother; 2021 Feb; 134():111162. PubMed ID: 33360932
[TBL] [Abstract][Full Text] [Related]
19. [Overexpression of human EP4 receptor in vascular smooth muscle cells attenuates angiotensin II-induced hypertension in mice].
Xu H; Wang SL; Bao CZ; Ye L; Guan YF; Zhang XY
Sheng Li Xue Bao; 2021 Aug; 73(4):597-605. PubMed ID: 34405216
[TBL] [Abstract][Full Text] [Related]
20. Inhibitory effect of D3 dopamine receptor on migration of vascular smooth muscle cells induced by synergistic effect of angiotensin II and aldosterone.
Li Y; Wang N; Chen C; He D; Yang J; Zeng C
Clin Exp Hypertens; 2015; 37(4):288-93. PubMed ID: 25496286
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
